| Literature DB >> 31428977 |
Jianfeng Jin1, Astrid D Bakker1, Gang Wu2, Jenneke Klein-Nulend1, Richard T Jaspers3.
Abstract
PURPOSE OF REVIEW: Bone and muscle mass increase in response to mechanical loading and biochemical cues. Bone-forming osteoblasts differentiate into early osteocytes which ultimately mature into late osteocytes encapsulated in stiff calcified matrix. Increased muscle mass originates from muscle stem cells (MuSCs) enclosed between their plasma membrane and basal lamina. Stem cell fate and function are strongly determined by physical and chemical properties of their microenvironment, i.e., the cell niche. RECENTEntities:
Keywords: Mechanical stimuli; Mechanosensing; Mechanotransduction; Myoblast; Osteocyte; Physicochemical niche conditions
Mesh:
Year: 2019 PMID: 31428977 PMCID: PMC6817749 DOI: 10.1007/s11914-019-00522-0
Source DB: PubMed Journal: Curr Osteoporos Rep ISSN: 1544-1873 Impact factor: 5.096
Fig. 1The process of how mechanical stimulation affects osteocytes and myoblasts within their native niche. Bone and muscle mass are regulated by many factors that include growth factors, hormones, nutrition, genetics, and, in particular, mechanical stimulation, e.g., tensile stress and shear stress upper panel shows the early and late osteocytes in their lacuna making contact with each other via their lamipodia extending through the canaliculi making contact with each other and with osteoblasts at the endosteum. Note that the late osteocyte is embedded within its calcified matrix while the matrix of the early osteocyte matrix is in a premature state of calcification. Due to the differences in calcification and stiffness, early osteocytes are likely subjected to pressure as well as tensile and shear deformations, while late osteocytes are subjected to fluid shear stress causing mechanical loading of transmembrane complexes and glycocalyx and presumably small local deformations within the plasma membrane at the cell body and lamipodia. MuSCs are enclosed between the sarcolemma of the host myofiber and the basal lamina and have transmembrane complexes via which the MuSC is connected to these structures. Upon shortening of the myofibers, MuSCs will be subjected to pressure and when myofibers are stretched, these cells will be strained and subjected to shear forces
Cellular chemical signaling molecules
| Molecule | Function | Relationship | References |
|---|---|---|---|
| NO | Modulation of osteoblast and osteoclast activity; produced after mechanical stimulation | L-arginine, NOS enzyme, molecular oxygen, NADPH, other cofactors | [ |
| Ca2+ | Regulation of cell or muscle contraction, cell motility, growth, proliferation | MTORC1, TrpV1, CaMKKα | [ |
| Prostaglandins | Modulation of bone quantity and quality | EP2 receptor, fascin, COX-like enzyme, linker of nucleoskeleton, and cytoskeleton complex | [ |
| BMPs | Induction of ectopic bone formation | Smads, TGF-β, activins | [ |
| Wnt/β-catenin | Modulation of osteoprogenitor proliferation; lineage selection | Axin, Dsh, GSK3, APC, PP2A, MYC, CCND1, LRP5 | [ |
| bFGF | Upregulation of eNOS expression; downregulation of RANKL expression | ERK1/2, c-Jun kinase (JNK), deltafosB, CREB, GEFs | [ |
| OPN | Regulation of bone cell differentiation; regulation of muscle size | Integrin-αv, integrin-β1, arginine-glycine-aspartate-containing glycoprotein | [ |
| OGN | Regulation of cell adhesion, proliferation, differentiation, migration in tissue development and repair | Alkaline phosphatase, collagen type I, β-catenin | [ |
| IGF-1 | Stimulation of muscle fiber growth; regulation of bone mass | PI3K/Akt/mTOR pathway, Murf1, MAFfbx | [ |
| HGF | Stimulation of muscle cell regeneration; involved in bone formation and bone resorption | c-Met | [ |
| VEGF | Regulation of oxidative metabolism of bone and muscle cells | Mechanical stimuli, hormones, growth factors, and transcription factors | [ |
| MAPK | Upregulation of eNOS expression; downregulation of RANKL | ERK1/2, c-Jun kinase (JNK), deltafosB, CREB, GEFs | [ |
| Myostatin | Linkage of muscle atrophy with bone loss | Glucocorticoid | [ |
| IL-4 | Stimulation of bone cell proliferation; modulation of signaling pathways | MAPK, PI3K, mTOR | [ |
| IL-6 | Stimulation of insulin-stimulated glucose uptake; regulation of muscle fiber size; modulation of osteogenesis and bone resorption | AMPK | [ |
BMP bone morphogenetic protein, bFGF basic fibroblast growth factor, OPN osteopontin, OGN osteoglycin, IGF-1 insulin-like growth factor-1, HGF hepatocyte growth factor, VEGF vascular endothelial growth factor, MAPK mitogen-activated protein kinase, IL interleukin, NADPH nicotinamide adenine dinucleotide phosphate, mTORC1 mammalian target of rapamycin complex 1, TrpV1 transient receptor potential cation channel subfamily V, CaMKKα Ca2+/calmodulin-dependent protein kinase kinase α, EP2 prostaglandin E2 receptor 2, COX cyclooxygenase, Smad mothers against decapentaplegic homolog, TGF-β transforming growth factor-β, Axin axis inhibition protein, Dsh disheveled, GSK3 glycogen synthase kinase 3, APC adenomatous polyposis coli, PP2A protein phosphatase 2, MYC myelocytomatosis, CCND1 cyclin D1, LRP5 lipoprotein receptor-related protein 5, ERK extracellular signal-regulated kinase, CREB cAMP-response-element binding protein, AMPK AMP-activated protein kinase
Fig. 2The experimental design to study interactions between the glycocalyx and ion channels of a cell in response to PFF. “Before” (pre-loading): with or without glycocalyx degradation and blocking of stretch-activated ion channels. “Treatment”: glycocalyx degradation and blocking of stretch-activated ion channels. “After”: NO production by C2C12 myoblasts in response to PFF with or without glycocalyx degradation and blocking stretch-activated ion channels. Myoblasts were seeded on a glass slide and cultured for 3 days, during which a glycocalyx was formed [15•]. Enzymatic removal of the glycocalyx from the cell surface was done by treatment with hyaluronic acid [15•, 100]. Stretch-activated ion channels were blocked by gadolinium chloride. Cells were stimulated by 1 h PFF, and NO production was measured after 0, 5, 10, 15, and 30 min [15•]. PFF, pulsating fluid flow
Fig. 3Changes in F-actin content and orientation with a bone cell subjected to PFF. MC3T3-E1 pre-osteoblasts were seeded on a glass slide, cultured for 3 days, treated with or without 1 h pulsating fluid flow (PFF), and fixed using 4% paraformaldehyde. F-actin was stained with rhodamine-phalloidin (green). Nuclei were stained with DAPI (blue). a Static control cell showing that F-actin stress fibers are woven into the complex network structure. b PFF-treated cell showing that F-actin stress fiber bundles are oriented and neatly organized in bundles. Magnification, × 100
Fig. 4The changes in apex height of a live muscle cell subjected to static shear stress (SSS). This diagram is based on studies as described by Boers et al. [93••]. C2C12 myoblasts were seeded on a glass slide and cultured for 72 h [93••]. Cells were live-stained for F-actin (Sir-actin, red) and nucleic acid (Syto-9, green) for 4 h. Then the cell was subjected to SSS at 0.97 Pa for 3 min. Confocal microscopy was used to record the cross-sectional video of the cell (XZ direction). At 0 s, the longitudinal apex of cell and nucleus were highest. After SSS application for 7 s, the longitudinal apex of the cell and nucleus transiently collapsed. However, after 30 s, the C2C12 myoblast regained to a certain extent its original morphology
Fig. 5Live cell images of MC3T3-E1 pre-osteoblast deformation in response to static shear stress (SSS). Pre-osteoblasts were seeded on a glass slide and cultured for 24 h. Cells were stained for F-actin (Sir-actin, red) and nucleic acids (Syto-9, green) for 4 h. Then the cells were subjected to SSS (0.97 Pa) for 3 min [102]. Confocal microscopy was used to record a series of cross-sectional images of the cell (XZ direction). a Distribution of F-actin fiber and DNA before SSS treatment. b Distribution of F-actin fiber and DNA after SSS treatment for 7 s. c Structure of F-actin and nucleus in an SSS-treated cell after 12 s. d Structure of F-actin and nucleus in an SSS-treated cell after 13 s. e Structure of F-actin and nucleus in an SSS-treated cell after 13.7 s. f Structure of F-actin and nucleus within an SSS-treated cell after 14.7 s. g–j are the partial enlargement and correspond to the orange frames of c–f, respectively
Molecular markers associated with myocytes, myoblasts, and muscle stem cells
| Cell type | Molecular marker(s) | Reference |
|---|---|---|
| Myocyte | MyoD (+), myogenin (+), MHC (+), MCK(+) | [ |
| MuSC | MyoD (+/−), Myf5 (+/−), Pax7 (+), β1 integrin (+) CXCR4 (+), α7 integrin (+), CD34 (+), VCam1 (+), c-Met (+), Mcad (+) | [ |
| Myoblast | MyoD (+), Myf5 (+/−), Pax7 (+), β1 integrin(+), CXCR4 (+), α7 integrin (+), CD34 (+), VCam1 (+), and fibronectin (+) | [ |